Wyeth Ltd(Merged)

Wyeth Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Wyeth Ltd(Merged)

₹ 1,334 -2.24%
09 Dec 2014
Company website BSE: 500095 NSE: WYETH
About

Wyeth Limited is an India-based biopharmaceutical company. The company is engaged in manufacturing, marketing, trading and export of pharmaceuticals and consumer healthcare products.

[ add key points ]
Website BSE NSE
  • Market Cap ₹ Cr.
  • Current Price ₹ 1,334
  • High / Low ₹ /
  • Stock P/E
  • Book Value ₹ 146
  • Dividend Yield 0.00 %
  • ROCE 31.9 %
  • ROE 21.0 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 26.1%
  • Company has been maintaining a healthy dividend payout of 144%
  • Company's working capital requirements have reduced from 27.3 days to 16.7 days

Cons

  • Stock is trading at 9.14 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Multinational

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2011 Dec 2011 Mar 2012 Jun 2012 Sep 2012 Dec 2012 Mar 2013 Jun 2013 Sep 2013 Dec 2013 Mar 2014 Jun 2014 Sep 2014
149 138 153 168 157 171 182 167 171 161 180 193 208
106 110 102 119 120 140 138 142 152 141 141 155 161
Operating Profit 43 28 51 49 37 31 44 25 19 20 38 38 47
OPM % 29% 20% 33% 29% 24% 18% 24% 15% 11% 12% 21% 20% 23%
7 8 13 10 9 8 9 9 10 8 8 6 5
Interest 0 0 0 0 0 0 0 -0 0 0 0 0 0
Depreciation 2 2 1 1 1 1 1 1 1 1 1 1 1
Profit before tax 48 34 63 58 45 38 52 34 28 27 45 43 51
Tax % 29% 28% 31% 33% 33% 33% 32% 35% 35% 35% 34% 34% 35%
34 25 44 39 30 26 35 22 18 17 30 28 34
EPS in Rs 14.96 10.84 19.23 17.15 13.33 11.33 15.50 9.77 8.10 7.69 13.17 12.54 14.78
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Nov 2009 8m Mar 2011 16m Mar 2012 Mar 2013 Mar 2014 TTM
286 285 329 382 286 640 588 678 679 742
213 186 223 253 207 412 415 516 576 598
Operating Profit 73 99 106 129 79 228 173 162 103 143
OPM % 25% 35% 32% 34% 28% 36% 29% 24% 15% 19%
18 19 19 21 10 18 39 35 34 26
Interest 0 0 0 0 0 1 1 1 0 0
Depreciation 6 6 6 7 7 9 6 3 3 3
Profit before tax 84 111 118 142 82 236 205 193 134 166
Tax % 19% 17% 31% 30% 28% 30% 29% 33% 34%
68 92 81 100 59 165 145 130 88 109
EPS in Rs 29.83 40.69 35.89 43.91 25.99 72.81 63.74 57.30 38.73 48.18
Dividend Payout % 84% 74% 84% 74% 77% 30% 28% 30% 375%
Compounded Sales Growth
10 Years: %
5 Years: 12%
3 Years: 2%
TTM: 7%
Compounded Profit Growth
10 Years: %
5 Years: -3%
3 Years: -19%
TTM: 8%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: 30%
3 Years: 26%
Last Year: 21%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Nov 2009 Mar 2011 Mar 2012 Mar 2013 Mar 2014
Equity Capital 23 23 23 23 23 23 23 23 23
Reserves 223 234 236 249 255 362 459 544 247
2 2 2 2 2 2 2 2 2
106 122 132 158 124 112 165 223 232
Total Liabilities 354 381 393 432 404 499 649 792 504
47 43 39 38 31 26 24 24 24
CWIP 0 1 3 1 2 2 2 0 0
Investments 0 0 0 0 0 0 0 0 0
306 336 351 393 371 472 624 768 479
Total Assets 354 381 393 432 404 499 649 792 504

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Nov 2009 Mar 2011 Mar 2012 Mar 2013 Mar 2014
61 79 86 60 58 151 76 92 119
11 14 13 14 10 12 31 32 29
-52 -65 -80 -80 -86 -94 -19 -48 -430
Net Cash Flow 20 28 18 -6 -18 69 89 76 -282

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Nov 2009 Mar 2011 Mar 2012 Mar 2013 Mar 2014
Debtor Days 25 25 25 23 25 19 34 24 27
Inventory Days 168 198 139 177 228 128 207 247 179
Days Payable 97 104 120 165 171 109 139 188 202
Cash Conversion Cycle 97 118 44 36 82 39 102 83 4
Working Capital Days 4 -9 -20 6 45 27 38 27 17
ROCE % 43% 45% 54% 30% 72% 46% 37% 32%

Shareholding Pattern

Numbers in percentages

Shareholding pattern is currently not available for this company.

Documents

Announcements

All

No data available.

Annual reports